Company Overview
More
Yao Ming Biotechnology Co., Ltd. is an investment holding company mainly providing biological agent discovery, development and production services. The company's technology platform includes WuXiBody TM bispecific antibody technology platform and antibody coupling drug (ADC) technology platform. It introduces a number of new projects to R & D pipelines. The company has a vaccine production base that produces vaccines for customers to supply the global market. The company operates in China, North America, Europe and other overseas markets.
CEO： Ge Li
Market： Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
02269 WUXI BIO
56.300+4.100+7.85%
Closed 05/20 16:08 CCT
High
56.900
Open
52.650
Turnover
1.32B
Low
52.650
Pre Close
52.200
Volume
23.89M
Price Forecast
No Data
News
Comment
WUXI BIO: Annual Report 2021
WUXI BIO: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
WUXI BIO: DATE OF BOARD MEETING
WUXI BIO: POSITIVE PROFIT ALERT
WUXI BIO: Interim Report 2021
WUXI BIO: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2021
WUXI BIO: DATE OF BOARD MEETING
WUXI BIO: POSITIVE PROFIT ALERT
WUXI BIO: Annual Report 2020
WUXI BIO: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020